Virtus ETF Advisers’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
Other funds holding CVAC
GCP
Virtus ETF Advisers's CVAC Position: Q1 2025 in Review
Virtus ETF Advisers sold out of CureVac (CVAC) in Q1 2025, closing a stake of 22,216 shares — an estimated $75.8K sold.
Virtus ETF Advisers first reported a position in CVAC in Q4 2020 and held it in 17 quarters. The position peaked at $227K in Q1 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q1 2025.
- Virtus ETF Advisers reported no remaining CureVac position as of Q1 2025 after selling out during the quarter.
- Virtus ETF Advisers sold 22,216 CureVac shares in Q1 2025, an estimated $75.8K.
- Virtus ETF Advisers first reported a position in CureVac in Q4 2020 and held it in 17 quarters.
- Virtus ETF Advisers's CureVac position peaked at $227K in Q1 2021.
- 83 funds tracked by Wall St. Rank held CureVac as of Q1 2025.
Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.